Youth PHP Pilot Transdiagnostic Treatment Implementation and Effectiveness Study
PHP TIES
PHP TIES: Pilot Transdiagnostic Treatment Implementation and Effectiveness Study for Youth Emotional Disorders in a Partial Hospitalization Program
1 other identifier
observational
304
1 country
1
Brief Summary
The purpose of this study is to examine patient effectiveness outcomes of a transdiagnostic treatment for youth emotional disorders, implemented in a partial hospitalization program (PHP). Participants will be youth between ages 6 to 17 and their families, as well as clinicians, participating in the PHP program at Children's Hospital Colorado. Additionally, the research team will study modifications to the transdiagnostic intervention that are required to feasibly and effectively deliver it in a PHP setting.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 15, 2021
CompletedFirst Posted
Study publicly available on registry
March 10, 2021
CompletedStudy Start
First participant enrolled
April 15, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 25, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
April 25, 2022
CompletedAugust 19, 2022
August 1, 2022
1 year
January 15, 2021
August 18, 2022
Conditions
Outcome Measures
Primary Outcomes (9)
Client satisfaction with treatment, as measured by the Client Satisfaction Questionnaire-8 (CSQ-8) at post-treatment
The CSQ-8 is an 8-item, self and parent-report measure of satisfaction with treatment services. Total scores range from 8 to 32, with higher scores indicating greater satisfaction with treatment services.
2 month
Client satisfaction with treatment, as measured by the Client Satisfaction Questionnaire-8 (CSQ-8) at 1 Month follow up
The CSQ-8 is an 8-item, self and parent-report measure of satisfaction with treatment services. Total scores range from 8 to 32, with higher scores indicating greater satisfaction with treatment services.
2 month
Change in anxiety symptoms, as measured by the Patient-Reported Outcomes Measurement Information System (PROMIS) Pediatric and Parent Proxy Anxiety Short Forms, Version 2.0
The PROMIS Pediatric and Parent Proxy Anxiety Short Form, Version 2.0 is an 8-item measuring assessing anxiety symptoms in youth. Total scores range from 8 to 40, with higher scores indicating greater anxiety symptoms.
Baseline, up to 2 month
Change in depression symptoms, as measured by the PROMIS Pediatric and Parent Proxy Depressive Symptoms Short Forms, Version 2.0
The PROMIS Pediatric and Parent Depressive Symptoms Short Form, Version 2.0 is a 6-item measuring assessing depressive symptoms in youth. Total scores range from 6 to 30, with higher scores indicating greater anxiety symptoms.
Baseline, up to 2 month
Change in emotional reactivity, as measured by the Emotion Dysregulation Inventory--Reactivity Short Form (EDI-R)
The EDI-R is a 7-item, parent report measure of emotional reactivity in youth. Total scores range from 0 to 35, with higher scores indicating greater emotional reactivity.
Baseline, up to 2 month
Change in functional impairment, as measured by the Brief Impairment Scale (BIS)
The BIS is a 23-item, parent report measure of functional impairment related to psychiatric symptoms in youth. Total scores range from 0 to 69, with higher scores indicating greater functional impairment.
Baseline, up to 2 month
Change in symptoms of disruptive and oppositional behavior, as measured by the Disruptive Behavior Rating Scale (DBRS)
The DBRS is an 8-item, parent report measure assessing symptoms of disruptive behaviors/oppositional defiant disorder in youth. Total scores range from 0 to 24, with higher scores indicating more disruptive/oppositional behaviors.
Baseline, up to 2 month
Change in anxiety sensitivity, as measured by the Childhood Anxiety Sensitivity Index (CASI)
The CASI is an 18-item self-report measure assessing fear of physiological symptoms of anxiety in youth. Total scores range from 18 to 56, with higher scores indicating greater anxiety sensitivity.
Baseline, up to 2 month
Change in distress intolerance, as measured by the Distress Intolerance Index for Youth (DIIY)
The DIIY is a 10-item, self and parent-report measure assessing youth perceived inability to tolerate negative emotional states and experiential discomfort. Total scores range from 10 to 50, with higher scores indicating greater distress intolerance.
Baseline, up to 2 month
Secondary Outcomes (9)
Change in parental accommodation of youth emotional disorder symptoms, as measured by the Family Accommodation Scale (FAS-E), adapted for youth emotional disorders symptoms
Baseline, up to 2 month
Change in positive and negative parenting behaviors, as measured by the Alabama Parenting Questionnaire--Short Form (APQ-S)
Baseline, up to 2 month
Change in parents' perceived self-efficacy in parenting their child, as measured by the Parenting Sense of Competence--Parenting Self Efficacy Scale (PSOC)
Baseline, up to 2 month
Change in youth cognitive reappraisal, as measured by the Emotion Regulation Questionnaire for Children and Adolescents--Reappraisal Scale (ERQ-CA)
Baseline, up to 2 month
Change in youth perceived self-efficacy, as measured by the PROMIS Self Efficacy scale
Baseline, up to 2 month
- +4 more secondary outcomes
Study Arms (1)
PHP Youth
Youth ages 6-17 receiving standard of care treatment (i.e., transdiagnostic intervention for emotional disorders) in a partial hospitalization program
Interventions
The Unified Protocols for Transdiagnostic Treatment of Emotional Disorders in Children and Adolescents (UP-C and UP-A) are transdiagnostic, behavioral interventions for youth with emotional disorders, including anxiety, depression, obsessive-compulsive disorders, and irritability.
Eligibility Criteria
Participants will be youth and parents recruited from the partial hospitalization program at Children's Hospital Colorado.
You may qualify if:
- youth between the ages of 6 and 17
- participation in treatment in the Children's Hospital Colorado (CHCO) PHP program
- presence of at least one caregiver available and willing to participate in the study.
- psychologist, licensed master's-level clinician (i.e., "behavioral health clinician"), or unlicensed "behavioral health specialist" providing clinical services through the CHCO Partial Hospitalization Program during the period of study enrollment
You may not qualify if:
- Patients will be excluded from the study if:
- they are a ward of the state
- are not enrolled in the Children's Hospital Colorado PHP program.
- Clinicians will be excluded from the study if:
- they are not providing clinical services through the Children's Hospital Colorado PHP program
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Colorado, Denverlead
- American Psychological Foundationcollaborator
- Children's Hospital Coloradocollaborator
Study Sites (1)
Children's Hospital Colorado
Aurora, Colorado, 80045, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Sarah M Kennedy, PhD
University of Colorado, Denver
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 15, 2021
First Posted
March 10, 2021
Study Start
April 15, 2021
Primary Completion
April 25, 2022
Study Completion
April 25, 2022
Last Updated
August 19, 2022
Record last verified: 2022-08
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, ANALYTIC CODE
- Time Frame
- Data will be available immediately following publication and ending 5 years after publication.
- Access Criteria
- Researchers who provide a methodologically sound proposal or reason for accessing the data will be granted access.
Individual participant data that underlie results reported in any published studies will be shared upon publication, after deidentification.